{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:19:47Z","timestamp":1791980387770,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008510","name":"University of Maryland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ejmech.2019.06.031","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T21:20:09Z","timestamp":1560547209000},"page":"84-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies"],"prefix":"10.1016","volume":"179","author":[{"given":"Dongdong","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Mackowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Hedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Heyward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4132-9887","authenticated-orcid":false,"given":"Fengtian","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.06.031_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/1381612805666230110214512","article-title":"An overview of cyclophosphamide development and clinical applications","volume":"5","author":"Colvin","year":"1999","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.06.031_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/blood-2012-06-436691","article-title":"The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies","volume":"121","author":"Wang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2019.06.031_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0163-7258(88)90004-6","article-title":"Metabolism of oxazaphosphorines","volume":"37","author":"Sladek","year":"1988","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2019.06.031_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/1381612805666230110215458","article-title":"The chemistry of the metabolites of cyclophosphamide","volume":"5","author":"Ludeman","year":"1999","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.06.031_bib5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1681\/ASN.V1281615","article-title":"Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide","volume":"12","author":"Dubourg","year":"2001","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2019.06.031_bib6","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1101\/gad.846800","article-title":"Reciprocal activation of xenobiotic response genes by nuclear receptors SXR\/PXR and CAR","volume":"14","author":"Xie","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2019.06.031_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0026-895X(24)12603-X","article-title":"Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor","volume":"60","author":"Goodwin","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.031_bib8","doi-asserted-by":"crossref","first-page":"12822","DOI":"10.1074\/jbc.M005930200","article-title":"Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics","volume":"276","author":"Smirlis","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.06.031_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.apsb.2012.02.004","article-title":"Oxazaphosphorine bioactivation and detoxification the role of xenobiotic receptors","volume":"2","author":"Wang","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2019.06.031_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/35019116","article-title":"Humanized xenobiotic response in mice expressing nuclear receptor SXR","volume":"406","author":"Xie","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.06.031_bib11","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1210\/mend.16.5.0828","article-title":"Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors","volume":"16","author":"Moore","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejmech.2019.06.031_bib12","doi-asserted-by":"crossref","first-page":"15122","DOI":"10.1074\/jbc.M001215200","article-title":"Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands","volume":"275","author":"Moore","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.06.031_bib13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0026-895X(25)14557-4","article-title":"1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, a potent phenobarbital-like inducer of microsomal monooxygenase activity","volume":"18","author":"Poland","year":"1980","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.031_bib14","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/MCB.20.9.2951-2958.2000","article-title":"The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR","volume":"20","author":"Tzameli","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejmech.2019.06.031_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/toxsci\/kft243","article-title":"Flame retardant BDE-47 effectively activates nuclear receptor CAR in human primary hepatocytes","volume":"137","author":"Sueyoshi","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejmech.2019.06.031_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/dmdi-2013-0009","article-title":"An update on the constitutive androstane receptor (CAR)","volume":"28","author":"Molnar","year":"2013","journal-title":"Drug Metab. Drug Interact."},{"key":"10.1016\/j.ejmech.2019.06.031_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11095-012-0895-1","article-title":"Identification of novel activators of constitutive androstane receptor from FDA-approved drugs by integrated computational and biological approaches","volume":"30","author":"Lynch","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2019.06.031_bib18","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1038\/srep10405","article-title":"Quantitative high-throughput identification of drugs as modulators of human constitutive androstane receptor","volume":"5","author":"Lynch","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.06.031_bib19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/toxsci\/kfy242","article-title":"Identification of modulators that activate the constitutive androstane receptor from the Tox21 10K compound library","volume":"167","author":"Lynch","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejmech.2019.06.031_bib20","doi-asserted-by":"crossref","first-page":"17277","DOI":"10.1074\/jbc.M300138200","article-title":"Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes","volume":"278","author":"Maglich","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.06.031_bib21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.molcel.2004.11.042","article-title":"A\u00a0structural basis for constitutive activity in the human CAR\/RXRalpha heterodimer","volume":"16","author":"Xu","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2019.06.031_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhep.2016.02.040","article-title":"Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue loss","volume":"65","author":"Tschuor","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ejmech.2019.06.031_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1074\/jbc.M117.806604","article-title":"Interaction of the phosphorylated DNA-binding domain in nuclear receptor CAR with its ligand-binding domain regulates CAR activation","volume":"293","author":"Shizu","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.06.031_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00649-16","article-title":"Phosphorylated nuclear receptor CAR forms a homodimer to repress its constitutive activity for ligand activation","volume":"37","author":"Shizu","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejmech.2019.06.031_bib25","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.bbagrm.2016.03.007","article-title":"Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARalpha in primary human hepatocytes","volume":"1859","author":"Kandel","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2019.06.031_bib26","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1021\/acs.jmedchem.5b01891","article-title":"2-(3-Methoxyphenyl)quinazoline derivatives: a new class of direct constitutive androstane receptor (CAR) agonists","volume":"59","author":"Smutny","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.031_bib27","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bcp.2011.08.027","article-title":"Use of comprehensive screening methods to detect selective human CAR activators","volume":"82","author":"Kublbeck","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.031_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0968-0896(00)00239-X","article-title":"A\u00a0new inhibitor design strategy for carboxypeptidase A as exemplified by N-(2-chloroethyl)-N-methylphenylalanine","volume":"9","author":"Park","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.031_bib29","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.bmc.2016.01.059","article-title":"Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors","volume":"24","author":"Samala","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.031_bib30","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.bmcl.2017.03.090","article-title":"Generation of tricyclic imidazo[1,2-a]pyrazines as novel PI3K inhibitors by application of a conformational restriction strategy","volume":"27","author":"Martinez Gonzalez","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.06.031_bib31","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1002\/anie.201407494","article-title":"Photomechanical actuation of ligand geometry in enantioselective catalysis","volume":"53","author":"Kean","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.06.031_bib32","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1021\/jm040888s","article-title":"Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline","volume":"48","author":"Andreani","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.031_bib33","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1016\/j.tetlet.2014.10.023","article-title":"N-Benzylazacyclophane synthesis via aromatic Mannich reaction","volume":"55","author":"D\u00edaz-Oviedo","year":"2014","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.06.031_bib34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bioorg.2018.02.005","article-title":"Synthesis and biological evaluation of imidazo[2,1-b]thiazole-benzimidazole conjugates as microtubule-targeting agents","volume":"77","author":"Baig","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.06.031_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jhet.5570340241","article-title":"A\u00a0new and facile synthesis of imidazo[2,1-b]oxazoles","volume":"34","author":"Mekonnen","year":"1997","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2019.06.031_bib36","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0090-9556(25)07564-6","article-title":"Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products","volume":"22","author":"Mizutani","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2019.06.031_bib37","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.111.188854","article-title":"An insulin-like growth factor 1 receptor inhibitor induces CYP3A4 expression through a pregnane X receptor-independent, noncanonical constitutive androstane receptor-related mechanism","volume":"340","author":"Li","year":"2012","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.06.031_bib38","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1021\/ci300245q","article-title":"ToxAlerts: a Web server of structural alerts for toxic chemicals and compounds with potential adverse reactions","volume":"52","author":"Sushko","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.06.031_bib39","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bcp.2008.08.014","article-title":"Discovery of substituted sulfonamides and thiazolidin-4-one derivatives as agonists of human constitutive androstane receptor","volume":"76","author":"Kublbeck","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.031_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.106.112136","article-title":"Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers","volume":"320","author":"Faucette","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.06.031_bib41","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1021\/jm200719v","article-title":"7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents","volume":"54","author":"Kiselev","year":"2011","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419305598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419305598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:56:21Z","timestamp":1759326981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419305598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":41,"alternative-id":["S0223523419305598"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.031","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}